Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158.14 ...

Your genes play a major role in determining your height, hair and eye color, and skin tone, but they don't tell the entire ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...

The Government of Canada is making a major push into genomics, investing $175.1 million to turn cutting-edge research into real-world breakthroughs in healthcare, agriculture, and clean technology.

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

International collaboration in genomic research is gaining momentum in African countries and is often supported by external ...

India is advancing medical innovation with artificial intelligence and genomics in Unani medicine, said Jitendra Singh, Union ...